SEC Form 4 · accession 0001179110-15-009536
MERRIMACK PHARMACEUTICALS INC · MACK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Birgit M. Schoeberl
Officer — Head of Discovery
Period of report
Jun 9, 2015
Accepted (ET)
Jun 11, 2015 · 8:23 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274792
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 9, 2015 | M | 62,057 | $2.12 | A | 65,657 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.12 | Jun 9, 2015 | M | 62,057 | D | — | Nov 5, 2019 | Common Stock | 62,057 | 0 | D |
Explanation of responses
- F1This option is fully vested.